Recombinant Cynomolgus CD200/OX-2 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00844P-100UG

Cynomolgus CD200 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Cynomolgus CD200/OX-2 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00844P-100UG
Collections: Car-nk targets proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Cynomolgus CD200/OX-2 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Gln56-Gly257. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | A0A2K5TQS2 |
Target Symbol | CD200/OX-2 |
Species | Cynomolgus |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Gln56-Gly257 |
Mol. Weight | The protein has a predicted MW of 23.66 kDa. Due to glycosylation, the protein migrates to 45-55 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Cynomolgus CD200, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Human CD200 R1, hFc Tag with the EC50 of 6.2ng/ml determined by ELISA (QC Test). The affinity constant of 35.84 nM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | CD200 and its receptors are highly expressed in the lung, on epithelial cells and leukocytes, and emerging evidence links dysregulation of the CD200 pathway with asthma. Moreover, pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models. |